Open AccessSystemic lupus erythematosus and COVID-19 during pregnancy
Author(s) -
H. T. Smeele,
L. F. Perez-Garcia,
Koen Grimminck,
Sam Schoenmakers,
A. Mulders,
Radboud J E M Dolhain
Publication year - 2021
Publication title -
lupus
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.069
H-Index - 103
eISSN - 1477-0962
pISSN - 0961-2033
DOI - 10.1177/09612033211002270
Subject(s) - medicine , pregnancy , discontinuation , covid-19 , pandemic , disease , systemic lupus erythematosus , watchful waiting , hydroxychloroquine , lupus erythematosus , pediatrics , intensive care medicine , immunology , infectious disease (medical specialty) , genetics , antibody , prostate cancer , cancer , biology
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is currently lacking. Methods: Herein, we describe the clinical presentation of 2 pregnant patients with SLE and mild symptomatic COVID-19 infection. Results: In both pregnant SLE patients, a watchful-waiting approach without initiation of treatment for COVID-19 was taken. No adverse outcomes were reported and both pregnancies resulted in healthy neonates born at term. In one patient we observed a flare in SLE disease activity, most likely attributed to discontinuing SLE treatment. Conclusion: Our report highlights the importance of multidisciplinary collaboration between health care professionals as well as individualized treatment decisions during unprecedented periods such as the current COVID-19 pandemic. Discontinuation of immunosuppressive drugs during the acute phase of a COVID-19 infection should be considered on a case-by-case basis. Maternal treatment decisions should be in line with current recommendations for treatment of rheumatic and musculoskeletal diseases during COVID-19 infection and in line with treatment of COVID- 19 during pregnancy.